Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 401788-99-6 | MDL No. : | MFCD03095438 |
Formula : | C10H16F6NP | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | XBSZSSGZQFAUPF-UHFFFAOYSA-N |
M.W : | 295.20 | Pubchem ID : | 11254899 |
Synonyms : |
|
Num. heavy atoms : | 18 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.5 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 6.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 62.99 |
TPSA : | 17.47 Ų |
GI absorption : | Low |
BBB permeant : | No |
P-gp substrate : | Yes |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -8.16 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | -0.08 |
Log Po/w (WLOGP) : | 7.99 |
Log Po/w (MLOGP) : | 2.94 |
Log Po/w (SILICOS-IT) : | 2.44 |
Consensus Log Po/w : | 2.66 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 1.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.67 |
Solubility : | 6.33 mg/ml ; 0.0215 mol/l |
Class : | Very soluble |
Log S (Ali) : | 0.16 |
Solubility : | 432.0 mg/ml ; 1.46 mol/l |
Class : | Highly soluble |
Log S (SILICOS-IT) : | -3.17 |
Solubility : | 0.198 mg/ml ; 0.000671 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 2.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 1.55 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
87% | With piperidine In ethanol at 75℃; for 12h; | Synthesis of TpsPym. 5-(diphenylamino)thiophene-2-carbaldehyde (2.79 g, 10 mmol) and M (pyridinium salt derivative, see Supporting information) (2.35 g, 10 mmol) were separately dissolved in ethanol, and 8 drops piperidine were added dropwise. The solution was reacted for 12 h at 75 °C, changing from colorless to red. After cooling to room temperature, the precipitate was collected by filtration, washed by ethanol, and then removed solvent in vacuum, got red solids. TpsPym: Yield 87%. 1H NMR (d6-DMSO, 400MHz , ppm): δ 8.75 (d, J=6.3Hz, 2H), 8.05 (dd, J1=40.0, J2=10.9Hz, 3H), 7.43 (t, J=7.4Hz, 4H), 7.26 (dd, J1=16.0, J2=8.0Hz, 7H), 6.74 (d, J=15.7Hz, 1H), 6.44 (d, J=3.9Hz, 1H), 4.44 (dt, J1=14.6, J2=7.2Hz, 2H), 1.96 - 1.64 (m, 2H), 1.27 (dt, J1=14.8, J2=7.4Hz, 2H), 0.98 - 0.76 (m, 3H); 13C NMR (d6-DMSO, 100MHz , ppm) :δ 157.21, 146.35, 144.05, 142.72, 141.02, 138.09, 136.41, 133.51, 129.83, 127.02, 124.87, 121.96, 72.01, 32.45, 21.15, 13.89; MS (ESI-MS): calc: 556.55, found: 411.19 (M-PF6-). |
[ 60804-74-2 ]
Tris(2,2'-bipyridine)ruthenium bis(hexafluorophosphate)
Similarity: 0.55
[ 667906-60-7 ]
(2-Fluoropyridin-4-yl)methanamine dihydrochloride
Similarity: 0.52
[ 1190319-70-0 ]
5-Fluoro-1H-pyrrolo[2,3-c]pyridine
Similarity: 0.51
[ 65350-59-6 ]
1-Butyl-4-methylpyridin-1-ium bromide
Similarity: 0.86
[ 26576-85-2 ]
1-Butyl-3-methylpyridin-1-ium bromide
Similarity: 0.81
[ 6159-05-3 ]
1,1'-Diheptyl-[4,4'-bipyridine]-1,1'-diium bromide
Similarity: 0.78
[ 123-03-5 ]
1-Hexadecylpyridin-1-ium chloride
Similarity: 0.76